Elpetrigine

DB19653ExperimentalSmall molecule

Elpetrigine is a small molecule drug. The usage of the INN stem '-trigine' in the name indicates that Elpetrigine is a sodium channel blocker, signal transduction modulator. Elpetrigine has a... Elpetrigine has a monoisotopic molecular weight of 287.97 Da.

Mechanism: Pharmacologically active on Voltage-dependent P/Q-type calcium channel subunit alpha-1A, Sodium channel protein type 2 subunit alpha, and Sodium channel protein type 3 subunit alpha
Curator reviewed
Formula / weight: C₁₀H₇Cl₃N₄ · 289.54 g/mol (avg)
Code names: JZP-4

Resolves to

Compound

UNII1X64S9H3ZSCAS212778-82-0ChEMBLCHEMBL29919ChEBI748083PubChem9926001

Structure

InChIKeyNNXUYJFHOVCRSM-UHFFFAOYSA-NSMILESNC1=CN=C(C(N)=N1)C1=CC(Cl)=CC(Cl)=C1Cl

Targets

O00555CACNA1AQ99250SCN2AQ9NY46SCN3AQ00975CACNA1B

What you can answer from here — as of September 23, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

15+ReferencesStructured and connected to the statements they support

Which drugs share a target with Elpetrigine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account